| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.4M+23.2% | $1.2M+26.3% | $917K+25.6% | $730K |
| Accounts receivable | $377K+4.2% | $361K+18.0% | $306K-18.9% | $377K |
| Prepaid expenses | $27K-2.7% | $28K+13.7% | $24K-5.7% | $26K |
| Total current assets | $1.8M+18.3% | $1.5M+23.6% | $1.3M+10.0% | $1.1M |
| Property and equipment, net of accumulated depreciation of $ 88,746 and $88,746, respectively | $0-100.0% | $2K-52.7% | $5K-35.5% | $7K |
| Total assets | $1.8M+18.2% | $1.5M+23.3% | $1.3M+9.7% | $1.1M |
| Accounts payable and accrued expense | $210K+35.7% | $155K+82.2% | $85K+45.8% | $58K |
| Accrued liability - related parties | $246K+47.2% | $167K+74.1% | $96K-17.0% | $115K |
| Deferred revenue | $348K+2.7% | $338K-6.0% | $360K+27.9% | $282K |
| Total current liabilities | $803K+21.7% | $660K+22.0% | $541K+18.8% | $455K |
| Total liabilities | $803K+21.7% | $660K+22.0% | $541K+14.0% | $474K |
| Commitments and Contingencies | $0 | $0 | $0 | $0 |
| Common stock, $0.001 par value, 70,000,000 authorized, 53,143,822 and 53,143,822 issued and outstanding, respectively | $53K+0.0% | $53K+0.0% | $53K+0.0% | $53K |
| Additional paid-in capital | $7.3M+1.7% | $7.2M+1.1% | $7.1M+2.2% | $7.0M |
| Accumulated other comprehensive income (loss) | $73K-9.6% | $81K+9.3% | $74K-2.5% | $76K |
| Accumulated deficit | -$6.4M+0.4% | -$6.5M+1.3% | -$6.6M-1.7% | -$6.4M |
| Total stockholders' equity | $1.0M+15.5% | $890K+24.3% | $716K+6.7% | $671K |
| Total liabilities and stockholders' equity | $1.8M+18.2% | $1.5M+23.3% | $1.3M+9.7% | $1.1M |
| Preferred Stock Share [Member] | ||||
| Series B Preferred convertible stock: $0.001 par value, 500,000 shares authorized, 193,661 issued and 193,661 outstanding, respectively | $194+0.0% | $194+0.0% | $194+3780.0% | $5 |
| Series B convertible preferred stock [Member] | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.